AI assistant
Victrex PLC — Board/Management Information 2020
Apr 3, 2020
5290_dirs_2020-04-03_d494bbd2-34ec-439a-8d0a-0d3b4e47b272.html
Board/Management Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6572I
Victrex PLC
03 April 2020
3 April 2020
Victrex plc - Director Declaration
Victrex plc, an innovative world leader in high performance polymer solutions, has been notified that Ros Rivaz, who will become Senior Independent Director and a Non-Executive Director of the Company with effect from 1 May 2020, has accepted a nomination to be a Non-Executive Director to the Board of Aperam SA, which is subject to a shareholder vote on 5 May 2020.
This announcement is made pursuant to paragraph 9.6.14 R of the Listing Rules.
About Victrex:
Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of automotive, aerospace, energy (including manufacturing & engineering), electronics and medical. Every day, millions of people use products and applications which contain our materials - from smartphones, aeroplanes and cars to oil and gas operations and medical devices. With over 40 years' experience, we develop world leading solutions in PEEK and PAEK based polymers, semi-finished and finished parts which shape future performance for our customers and our markets, and drive value for our shareholders. Find out more at www.victrexplc.com or follow us on LinkedIn and Twitter @victrexir
Enquiries:
Victrex plc:
Andrew Hanson, Director of Investor Relations & Corporate Communications
+44 (0) 1253 898121
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
RDNUUUBRROUSRAR